Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | CLK1 | P49759 | 1/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.33 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.33 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | HTR6 | P50406 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14327924 | 0.88 | NR1H2 (0.36) | NR1H2ALOX5MEN1KMT2A | |
| SCHEMBL2013305 | 0.87 | MCL1 (0.38) | NR1H2 | |
| SCHEMBL2013306 | 0.87 | MCL1 (0.38) | NR1H2 | |
| SCHEMBL2447541 | 0.82 | SRD5A2 (0.49) | ALOX5ALDH1A1MEN1KMT2A | |
| SCHEMBL2447542 | 0.82 | SRD5A2 (0.49) | ALOX5ALDH1A1MEN1KMT2A | |
| SCHEMBL2021474 | 0.82 | SRD5A2 (0.49) | ALOX5ALDH1A1MEN1KMT2A | |
| SCHEMBL2014413 | 0.81 | CLK1 (0.32) | CLK1DYRK1ADYRK1BGAAMAPK1 | |
| SCHEMBL2014416 | 0.81 | CLK1 (0.32) | CLK1DYRK1ADYRK1BGAAMAPK1 | |
| SCHEMBL2017568 | 0.80 | PRMT5 (0.37) | — | |
| SCHEMBL2017566 | 0.80 | PRMT5 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105816453-B | Substituted tricyclic acid derivatives as S1P1 receptor agonists for the treatment of autoimmune and inflammatory disorders | 艾尼纳制药公司 | 2021-03-05 | — | — | CN | disclosed |